Clusterin increases post-ischemic damages in organotypic hippocampal slice cultures

Journal of Neurochemistry

Volumn 106, Issue 4, 2008, Pages 1791-1803

  Hakkoum, David ^b,c   Imhof, Anouk ^b,c   Vallet, Philippe G ^b   Boze, Helène ^d   Moulin, Guy ^d   Charnay, Yves ^b   Stoppini, Luc ^e   Aronow, Bruce ^f   Bouras, Constantin ^b   Giannakopoulos, Panteleimon ^a,b,c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c University of Lausanne Medical Center   (Switzerland)

^d MONTPELLIER SUPAGRO   (France)

^e Capsant Neurotechnologies Ltd   (United Kingdom)

^f CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Clusterin; Glutamate receptors; Multi electrode array; Organotypic hippocampal slice cultures; Oxygen glucose deprivation

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; BIOCHEMICAL MARKER; CLUSTERIN; GLUCOSE; OXYGEN; PROPIDIUM IODIDE; SYNAPTOPHYSIN;

ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ELECTROPHYSIOLOGY; BRAIN ISCHEMIA; CELL DEATH; CELL FUNCTION; CELL NUCLEUS; CELL STRUCTURE; CONTROLLED STUDY; DRUG UPTAKE; FOOD DEPRIVATION; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SYNAPSE; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BRAIN ISCHEMIA; CELL HYPOXIA; CLUSTERIN; GLUCOSE; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; N-METHYLASPARTATE; ORGAN CULTURE TECHNIQUES; OXYGEN CONSUMPTION;

MUS;

EID: 48749120629     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05519.x     Document Type: Article

References (62)

1. Alonso d. L., Diez-Tejedor E., Carceller F. Roda J. M. (2001) Cerebral ischemia: from animal studies to clinical practice. Should the methods be reviewed? Cerebrovasc. Dis. 11 (Suppl 1 20 30.
2. Ammar H. Closset J. L. (2008) Clusterin activates survival through PI-3 kinase/AKT pathway. J. Biol. Chem. 283, 12851 12861.
3. Bell R. D., Sagare A. P., Friedman A. E., Bedi G. S., Holtzman D. M., Deane R. Zlokovic B. V. (2007) Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J. Cereb. Blood Flow Metab. 27, 909 918.
4. Bey E. A., Wuerzberger-Davis S. M., Pink J. J. et al. (2006) Mornings with art, lessons learned: feedback regulation, restriction threshold biology, and redundancy govern molecular stress responses. J. Cell. Physiol. 209, 604 610.
5. Bonde C., Noraberg J., Noer H. Zimmer J. (2005) Ionotropic glutamate receptors and glutamate transporters are involved in necrotic neuronal cell death induced by oxygen-glucose deprivation of hippocampal slice cultures. Neuroscience 136, 779 794.
6. Brown A. R., Webb J., Rebus S., Williams A. Fazakerley J. K. (2004) Identification of up-regulated genes by array analysis in scrapie-infected mouse brains. Neuropathol. Appl. Neurobiol. 30, 555 567.
7. Caccamo A. E., Desenzani S., Belloni L., Borghetti A. F. Bettuzzi S. (2006) Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells. J. Cell. Physiol. 207, 208 219.
8. Calero M., Rostagno A., Matsubara E., Zlokovic B., Frangione B. Ghiso J. (2000) Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc. Res. Tech. 50, 305 315.
9. Cheng H. W., Jiang T., Brown S. A., Pasinetti G. M., Finch C. E. McNeill T. H. (1994) Response of striatal astrocytes to neuronal deafferentation: an immunocytochemical and ultrastructural study. Neuroscience 62, 425 439.
10. Dati G., Quattrini A., Bernasconi L. et al. (2007) Beneficial effects of r-h-CLU on disease severity in different animal models of peripheral neuropathies. J. Neuroimmunol. 190, 8 17.
11. Dietz G. P. Bahr M. (2004) Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 27, 85 131.
12. Dragunow M., Preston K., Dodd J., Young D., Lawlor P. Christie D. (1995) Clusterin accumulates in dying neurons following status epilepticus. Brain Res. Mol. Brain Res. 32, 279 290.
13. Fan Y. F., Lu C. Z., Xie J., Zhao Y. X. Yang G. Y. (2006) Apoptosis inhibition in ischemic brain by intraperitoneal PTD-BIR3-RING (XIAP). Neurochem. Int. 48, 50 59.
14. French L. E., Sappino A. P., Tschopp J. Schifferli J. A. (1992) Distinct sites of production and deposition of the putative cell death marker clusterin in the human thymus. J. Clin. Invest. 90, 1919 1925.
15. Giannakopoulos P., Kovari E., French L. E., Viard I., Hof P. R. Bouras C. (1998) Possible neuroprotective role of clusterin in Alzheimer's disease: a quantitative immunocytochemical study. Acta Neuropathol. (Berl.) 95, 387 394.
16. Hakkoum D., Muller D. Stoppini L. (2006) Electrophysiological monitoring of hippocampal slice cultures using MEA on Porous membranes, in Advances in Network Electrophysiology (Taketani M. Baudry M., eds), pp. 112 116. Springer Science + Business Media, New York.
17. Hakkoum D., Stoppini L. Muller D. (2007) Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures. J. Neurochem. 100, 747 757.
18. Han B. H., DeMattos R. B., Dugan L. L. et al. (2001) Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat. Med. 7, 338 343.
19. Holtzman D. M. (2004) In vivo effects of ApoE and clusterin on amyloid-beta metabolism and neuropathology. J. Mol. Neurosci. 23, 247 254.
20. Imhof A., Charnay Y., Vallet P. G., Aronow B., Kovari E., French L. E., Bouras C. Giannakopoulos P. (2006) Sustained astrocytic clusterin expression improves remodeling after brain ischemia. Neurobiol. Dis. 22, 274 283.
21. Issaly N., Solsona O., Joudrier P., Gautier M. F., Moulin G. Boze H. (2001) Optimization of the wheat puroindoline-a in Pichia pastoris. J Appl Microbiol 90, 397 406.
22. Iwata A., Browne K. D., Chen X. H., Yuguchi T. Smith D. H. (2005) Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats. J. Neurosci. Res. 82, 103 114.
23. Jenne D. E. Tschopp J. (1992) Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem. Sci. 17, 154 159.
24. Jomary C., Darrow R. M., Wong P., Organisciak D. T. Jones S. E. (2004) Expression of neurturin, glial cell line-derived neurotrophic factor, and their receptor components in light-induced retinal degeneration. Invest. Ophthalmol. Vis. Sci. 45, 1240 1246.
25. Jones S. E. Jomary C. (2002) Clusterin. Int. J. Biochem. Cell Biol. 34, 427 431.
26. Klimaschewski L., Obermuller N. Witzgall R. (2001) Regulation of clusterin expression following spinal cord injury. Cell Tissue Res. 306, 209 216.
27. Kounnas M. Z., Loukinova E. B., Stefansson S., Harmony J. A., Brewer B. H., Strickland D. K. Argraves W. S. (1995) Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J. Biol. Chem. 270, 13070 13075.
28. Laake J. H., Haug F. M., Wieloch T. Ottersen O. P. (1999) A simple in vitro model of ischemia based on hippocampal slice cultures and propidium iodide fluorescence. Brain Res. Brain Res. Protoc. 4, 173 184.
29. Lee K.-B., Jeo J.-H., Choi I., Kwon O.-Y., Yu K. You K.-H. (2008) Clusterin, a novel modulator of TGF-beta signaling is involved in Smad 2/3 stability. Biochem. Biophys. Res. Commun. 366, 905 909.
30. Leskov K. S., Klokov D. Y., Li J., Kinsella T. J. Boothman D. A. (2003) Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 278, 11590 11600.
31. Liu L., Lioudyno M., Tao R., Eriksson P., Svensson M. Aldskogius H. (1999) Hereditary absence of complement C5 in adult mice influences Wallerian degeneration, but not retrograde responses, following injury to peripheral nerve. J. Peripher. Nerv. Syst. 4, 123 133.
32. Martinez-Sanchez M., Striggow F., Schroder U. H., Kahlert S., Reymann K. G. Reiser G. (2004) Na(+) and Ca(2 +) homeostasis pathways, cell death and protection after oxygen-glucose-deprivation in organotypic hippocampal slice cultures. Neuroscience, 128, 729 740.
33. May P. C. Finch C. E. (1992) Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration. Trends Neurosci. 15, 391 396.
34. McDonald J. W., Silverstein F. S. Johnston M. V. (1987) MK-801 protects the neonatal brain from hypoxic-ischemic damage. Eur. J. Pharmacol. 140, 359 361.
35. McLaughlin L., Zhu G., Mistry M. et al. (2000) Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J. Clin. Invest. 106, 1105 1113.
36. Michel D., Chabot J. G., Moyse E., Danik M. Quirion R. (1992) Possible functions of a new genetic marker in central nervous system: the sulfated glycoprotein-2 (SGP-2). Synapse 11, 105 111.
37. Pasinetti G. M., Johnson S. A., Oda T., Rozovsky I. Finch C. E. (1994) Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J. Comp. Neurol. 339, 387 400.
38. Quintana P., Alberi S., Hakkoum D. Muller D. (2006) Glutamate receptor changes associated with transient anoxia/hypoglycaemia in hippocampal slice cultures. Eur. J. Neurosci. 23, 975 983.
39. Ricci F., Pucci S., Sesti F., Missiroli F., Cerulli L. Spagnoli L. G. (2007) Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage. Ophthalmic Res. 39, 164 173.
40. Robert F., Bert L. Stoppini L. (2002) Blockade of NMDA-receptors or calcium-channels attenuates the ischaemia-evoked efflux of glutamate and phosphoethanolamine and depression of neuronal activity in rat organotypic hippocampal slice cultures. C R Biol. 325, 495 504.
41. Rosenberg M. E. Silkensen J. (1995b) Clusterin: physiologic and pathophysiologic considerations. Int. J. Biochem. Cell Biol. 27, 633 645.
42. Sasaki K., Doh-ura K., Ironside J. W. Iwaki T. (2002) Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies. Acta Neuropathol. 103, 199 208.
43. Scolding N. J., Morgan B. P. Compston D. A. (1998) The expression of complement regulatory proteins by adult human oligodendrocytes. J. Neuroimmunol. 84, 69 75.
44. Shin Y. J., Kang S. W., Jeong S. Y., Shim Y. J., Kim Y. H., Kim B. M., Kee S. H., Park J. J., Park I. S. Min B. H. (2006) Clusterin enhances proliferation of primary astrocytes through extracellular signal-regulated kinase activation. Neuroreport 17, 1871 1875.
45. Stoppini L., Buchs P. A. Muller D. (1991) A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37, 173 182.
46. Tornquist E., Liu L., Mattsson P. Svensson M. (1997) Response of glial cells and activation of complement following motorneuron degeneration induced by toxic ricin. Neurosci. Res. 28, 167 175.
47. Torres-Munoz J. E., Redondo M., Czeisler C., Roberts B., Tacoronte N. Petito C. K. (2001) Upregulation of glial clusterin in brains of patients with AIDs. Brain Res. 888, 297 301.
48. Trendelenburg G. Dirnagl U. (2005) Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia 50, 307 320.
49. Trougakos I. P. Gonos E. S. (2002) Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol. 34, 1430 1448.
50. Trougakos I. P., Lourda M., Agiostratidou G., Kletsas D. Gonos E. S. (2005) Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic. Biol. Med. 38, 436 449.
51. Van Beek J., Chan P., Bernaudin M., Petit E., MacKenzie E. T. Fontaine M. (2000) Glial responses, clusterin, and complement in permanent focal cerebral ischemia in the mouse. Glia 31, 39 50.
52. Walton M., Young D., Sirimanne E., Dodd J., Christie D., Williams C., Gluckman P. Dragunow M. (1996a) Induction of clusterin in the immature brain following a hypoxic-ischemic injury. Brain Res. Mol. Brain Res. 39, 137 152.
53. Wehrli P., Charnay Y., Vallet P. et al. (2001) Inhibition of post-ischemic brain injury by clusterin overexpression. Nat. Med. 7, 977 979.
54. White F., Nicoll J. A. Horsburgh K. (2001) Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion. Exp. Neurol. 169, 307 318.
55. Wicher G. K. Aldskogius H. (2005) Adult motor neurons show increased susceptibility to axotomy-induced death in mice lacking clusterin. Eur. J. Neurosci. 21, 2024 2028.
56. Wiggins A. K., Shen P. J. Gundlach A. L. (2003) Delayed, but prolonged increases in astrocytic clusterin (ApoJ) mRNA expression following acute cortical spreading depression in the rat: evidence for a role of clusterin in ischemic tolerance. Brain Res. Mol. Brain Res. 114, 20 30.
57. Wilson M. R. Easterbrook-Smith S. B. (2000) Clusterin is a secreted mammalian chaperone. Trends Biochem. Sci. 25, 95 98.
58. Wong P. (1994) Apoptosis, retinitis pigmentosa, and degeneration. Biochem. Cell Biol. 72, 489 498.
59. Xie Z., Harris-White M. E., Wals P. A., Frautschy S. A., Finch C. E. Morgan T. E. (2005) Apolipoprotein J (clusterin) activates rodent microglia in vivo and in vitro. J. Neurochem. 93, 1038 1046.
60. Yang C. R., Leskov K., Hosley-Eberlein K., Criswell T., Pink J. J., Kinsella T. J. Boothman D. A. (2000) Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc. Natl Acad. Sci. USA 97, 5907 5912.
61. Yerbury J. J., Poon S., Meehan S., Thompson B., Kumita J. R., Dobson C. M. Wilson M. R. (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J., 21, 2312 2322.
62. Zoli M., Ferraguti F., Zini I., Bettuzzi S. Agnati L. F. (1993) Increases in sulphated glycoprotein-2 mRNA levels in the rat brain after transient forebrain ischemia or partial mesodiencephalic hemitransection. Brain Res. Mol. Brain Res. 18, 163 177.